Anna Forsythe is the Founder and President of Oncoscope-AI, the first platform to bring together real-time oncology treatment data, clinical guidelines, research publications, and regulatory approvals — all in one place, just like Expedia for cancer care. Available free to oncology professionals worldwide, Oncoscope-AI is redefining how cancer care information is accessed and applied. A clinically trained Doctor of Pharmacy (PharmD), Anna also holds a Master’s in Health Economics and Policy from the University of Birmingham (UK) and an MBA from Columbia University. She previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020) and led Global Value and Access at Eisai Pharmaceuticals, following earlier roles at Novartis and Bayer in clinical research and health economics. Anna has taught health economics at Long Island University’s PharmD program, is a frequent speaker at major industry conferences, and has authored numerous publications in clinical research and health economics. Her 2022 JAMA pediatrics article, “Humanistic and Economic Burden of Conversion Therapy,” ranked in the top 5% of all JAMA research outputs worldwide.